Nektar, San Francisco, CA

Nektar

www.nektar.com

Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar`s proprietary and proven chemistry platform in the discovery and design of our new drug candidates.

Number of Employees: 250-1000
Annual Revenue: $10-50 Million

www.nektar.com
455 Mission Bay Boulevard South
San Francisco, CA USA 94158
Phone: 415.482.5300

Executives

Name	Title	Contact Details
Mark Wilson	Vice President and General Counsel	Profile
Wen Liu	VP Regulatory Affairs	Profile
Susan Evans	Vice President Intellectual Property	Profile
Carlo Difonzo	VP, Regulatory Affairs and Product Safety	Profile

Similar Companies

Prometheus Laboratories

Prometheus Laboratories Inc. is one of the leading companies in the Healthcare, Pharmaceuticals and Biotech sector.

Azopharma Contract Pharmaceutical Services

Azopharma Contract Pharmaceutical Services is a Miramar, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Oakwood Laboratories

Oakwood Laboratories is a Bedford, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Higher Dimension Research

Higher Dimension Research, Inc is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Sydnexis,

Sydnexis Inc. is a clinical stage biopharmaceutical company based in San Diego. They are currently evaluating their patented eyedrop formulation, SYD 101, in a Phase 3 clinical trial to decrease myopia progression in children.